RESEARCHthe analyses. Cases in persons who stayed in a hospital orother health care setting (e.g., nursing home or rehabilitationcenter) for >1 day during the 2–14 days before symptomonset were defined as nosocomial cases.Source Identification and Cluster DetectionPotential sources of infection were identified by MunicipalHealth Services (MHS) public health physicians andnurses, who used a standardized questionnaire to interviewpatients or relatives (online Technical Appendix 1, http://wwwnc.cdc.gov/EID/article/21/7/14-1130-Techapp1.<strong>pdf</strong>).The interview focused on tracking each patient’s exposureto potential sources of infection during the 2–14 days beforesymptom onset. All potential sources of infection wererecorded in a database by the LSIU and used to identifyclusters of LD cases by location and date. Each new LDcase in this database was examined to determine if reportedpotential sources were linked to other LD cases. Becauseoutbreaks of Legionnaires’ disease are often preceded andfollowed by small clusters of solitary cases (9), an arbitrarycluster definition was constructed that defined 2 types ofclusters: location and geographic. A location cluster, whichmay represent a local contamination, was defined as casesreported within 2 years of each other in >2 persons whowere reported to have been exposed to the same potentialsource of infection during the 2–14 days before symptomonset. A geographic cluster was defined as cases in>3 persons who lived 1 cluster. Data from thelocation cluster of the LD outbreak in Amsterdam in 2006(7) were excluded from our analyses.Sampling ProcedureAs part of the NLODP, the LSIU is available to each MHSto collect samples from potential sources of Legionellainfection for reported domestic LD cases. During 2002–2006, all identified potential sources of infection were investigated.However, because of budgetary reasons, afterJune 1, 2006, potential sources were investigated only if >1of 4 sampling criteria was met: 1) a patient-derived isolateof Legionella spp. (from respiratory secretions or lung tissue)was available; 2) a location cluster was identified; 3)a geographic cluster was identified; or 4) the patient hadstayed in a hospital or other health care setting during theincubation period. For geographic clusters, efforts werefocused on identifying yet undiscovered potential sources(e.g., cooling towers near patients’ residences). If >1 ofthe 4 sampling criteria was met, trained LSIU laboratorystaff collected water and swab samples from identified potentialsources when possible. For each location, samplingpoints were selected by LSIU staff in cooperation with thefacility’s technical team (when a team is available), and acomprehensive collection of water and swab samples wasobtained from that location for further analysis.Laboratory InvestigationsSamples collected during the source investigation wereanalyzed for the presence of Legionella spp. (for an extensivedescription, see online Technical Appendix 2, http://wwwnc.cdc.gov/EID/article/21/7/14-1130-Techapp2.<strong>pdf</strong>).All L. pneumophila serogroup 1 (SG1) strains (clinical andenvironmental) were subsequently genotyped by sequencebasedtyping, as recommended by the ESCMID StudyGroup for Legionella Infections (10–12), and further determinedby using the Dresden panel of monoclonal antibodies(13). The sequence-based typing profiles of the patientisolates were compared with those of the environmentalstrains found in samples of potential sources.Statistical AnalysesComparisons were made by using independent samples t-tests, nonparametric Mann-Whitney U-test, 2-tailed χ 2 tests(proportions), and linear regression analyses (trends overtime). All analyses were performed with PASW Statistics8.0 (SPSS Inc., Chicago, IL, USA).ResultsPatientsDuring August 2002–August 2012, a total of 2,796 LDcases were reported in the Netherlands, 805 (28.8%) ofwhich were nondomestic (Figure). These travel-associatedcases were excluded from the analyses, resulting in 1,991reported possible domestic LD cases (mean of 193 [SD 76]cases annually); 119 (6.0%) of these were characterized asnosocomial cases. Most patients (72%) for this period weremale (Table 1). The median age of reported case-patientsFigure. Legionnaires’ disease cases reported in the Netherlands,August 1, 2002–August 1, 2012. A total of 2,796 cases werereported; LD cases in persons who had been outside thecountry for >5 of 9 days before disease onset were defined asnondomestic cases and excluded from analyses. All other caseswere classified as domestic.1168 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 21, No. 7, July 2015
Legionella Outbreak Detection, the NetherlandsTable 1. Number and demographic characteristics of patientswith domestically acquired cases of Legionnaires’ disease, theNetherlands, 2002–2012*No. Median age, y Male patients,Yearpatients (range) no. (%)2002 35 55.3 (26.4–78.3) 24 (68.6)2003 112 57.4 (4.8–87.9) 73 (65.2)2004 153 57.3 (21.3–88.1) 113 (73.9)2005 179 59.1 (28.2–94.2) 132 (73.7)2006 285 60.2 (17.0–90.1) 193 (67.7)2007 195 59.1 (19.6–93.1) 153 (78.5)2008 227 60.2 (11.0–98.1) 158 (69.6)2009 150 61.3 (14.6–94.8) 106 (70.7)2010 344 61.5 (23.2–94.1) 249 (72.4)2011 208 62.2 (24.3–93.0) 155 (74.5)2012 103 62.5 (27.0–91.6) 73 (70.9)2002–2012 1,991 60.2 (4.8–98.1) 1,429 (71.8)*Study period was August 1, 2002–August 1, 2012. Patients who had beenout of the country for >5 of the 9 days before disease onset (n = 805) wereexcluded.increased from 55.3 (range 26.4–78.3) years in 2002 to62.5 (range 27.0–91.6) years in 2012 (Table 1; linear regression,p trend 1 Legionella spp. was found, identifiedas L. pneumophila SG1 or L. pneumophila non-SG1 if noL. pneumophila SG1 was found (Table 3). The proportionsbefore and after introduction of the 4 criteria for sampling onJune 1, 2006, were similar: 24.6% vs. 25.2%, respectively.L. pneumophila SG1 was found in 97 (6.5%) investigations,L. pneumophila non-SG1 in 76 (5.1%), and Legionellaspp. other than L. pneumophila in 194 (13.1%) (Table3). The proportion of investigations in which L. pneumophilaSG1 was found showed large variations among sourcetypes (Table 3). For instance, L. pneumophila SG1 was oftendetected in wellness centers (i.e., facilities offering spas,saunas, fitness equipment, massages, etc.) (40.5%); hospitalsand health care settings (25.6%); and cooling towers(20.9%). However, L. pneumophila SG1 was not detectedin investigated campsites, car wash or gasoline stations, ordecorative water fountains and was detected in only a smallproportion of investigated garden centers (1.2%). Residenceswere the most frequently sampled sources (51.3%of investigations); L. pneumophila SG1 was found in 21(2.8%) of the 762 investigated residences (Table 3). Exclusionof source investigation data for the 119 nosocomialcases did not markedly change these results (online TechnicalAppendix 2 Table 2).ClustersThe cluster definition used by NLODP resulted in 105 identifiedclusters, of which 98 (93.3%) were location clustersand 7 (6.7%) were geographic clusters. These clusters involved266 patients with LD (Table 4; online Technical Appendix2 Figure). An average of 2.9 (range 2–11) patientswith LD were associated with each cluster (some patientswere part of multiple clusters). In 50 clusters (47.6%), patientsfrom >1 MHS were involved. Garden centers were themost frequently identified cluster site (27 [25.7%] clusters),followed by hospitals and health care settings (17 [16.2%]Table 2. Characteristics of and test results for patients with domestically acquired Legionnaires’ disease, the Netherlands, 2002–2012*Characteristic Total, N = 1,991 Community acquired, n = 1,872 Nosocomial, n = 119 p value†Patient demographicsAge, y (SD) 60.2 (4.8–98.1) 60.0 (4.8–98.1) 68.9 (11.2–94.8)
- Page 3 and 4:
July 2015SynopsisOn the CoverMarian
- Page 5 and 6:
1240 Gastroenteritis OutbreaksCause
- Page 7 and 8:
SYNOPSISDisseminated Infections wit
- Page 9 and 10:
Disseminated Infections with Talaro
- Page 11 and 12:
Disseminated Infections with Talaro
- Page 13 and 14:
Macacine Herpesvirus 1 inLong-Taile
- Page 15 and 16:
Macacine Herpesvirus 1 in Macaques,
- Page 17 and 18:
Macacine Herpesvirus 1 in Macaques,
- Page 19:
Macacine Herpesvirus 1 in Macaques,
- Page 23: Malaria among Young Infants, Africa
- Page 26 and 27: RESEARCHFigure 3. Dynamics of 19-kD
- Page 28 and 29: Transdermal Diagnosis of MalariaUsi
- Page 30 and 31: RESEARCHFigure 2. A) Acoustic trace
- Page 32 and 33: RESEARCHof malaria-infected mosquit
- Page 34 and 35: Lack of Transmission amongClose Con
- Page 36 and 37: RESEARCH(IFA) and microneutralizati
- Page 38 and 39: RESEARCHoropharyngeal, and serum sa
- Page 40 and 41: RESEARCH6. Assiri A, McGeer A, Perl
- Page 42 and 43: RESEARCHadvanced genomic sequencing
- Page 44 and 45: RESEARCHTable 2. Next-generation se
- Page 46 and 47: RESEARCHTable 3. Mutation analysis
- Page 48 and 49: RESEARCHReferences1. Baize S, Panne
- Page 50 and 51: Parechovirus Genotype 3 Outbreakamo
- Page 52 and 53: RESEARCHFigure 1. Venn diagramshowi
- Page 54 and 55: RESEARCHTable 2. HPeV testing of sp
- Page 56 and 57: RESEARCHFigure 5. Distribution of h
- Page 58 and 59: RESEARCHReferences1. Selvarangan R,
- Page 60 and 61: RESEARCHthe left lobe was sampled b
- Page 62 and 63: RESEARCHTable 2. Middle East respir
- Page 64 and 65: RESEARCHseroprevalence in domestic
- Page 66 and 67: RESEARCHmeasure their current surve
- Page 68 and 69: RESEARCHTable 2. States with labora
- Page 70 and 71: RESEARCHFigure 2. Comparison of sur
- Page 72 and 73: RESEARCH9. Centers for Disease Cont
- Page 76 and 77: RESEARCHTable 3. Sampling results (
- Page 78 and 79: RESEARCHpresence of Legionella spp.
- Page 80 and 81: Seroprevalence for Hepatitis Eand O
- Page 82 and 83: RESEARCHTable 1. Description of stu
- Page 84 and 85: RESEARCHTable 3. Crude and adjusted
- Page 86 and 87: RESEARCHrates by gender or HIV stat
- Page 88 and 89: RESEARCH25. Taha TE, Kumwenda N, Ka
- Page 90 and 91: POLICY REVIEWDutch Consensus Guidel
- Page 92 and 93: POLICY REVIEWTable 3. Comparison of
- Page 94 and 95: POLICY REVIEW6. Botelho-Nevers E, F
- Page 96 and 97: DISPATCHESFigure 1. Phylogenetic tr
- Page 98 and 99: DISPATCHESSevere Pediatric Adenovir
- Page 100 and 101: DISPATCHESTable 1. Demographics and
- Page 102 and 103: DISPATCHES13. Kim YJ, Hong JY, Lee
- Page 104 and 105: DISPATCHESTable. Alignment of resid
- Page 106 and 107: DISPATCHESFigure 2. Interaction of
- Page 108 and 109: DISPATCHESSchmallenberg Virus Recur
- Page 110 and 111: DISPATCHESFigure 2. Detection of Sc
- Page 112 and 113: DISPATCHESFigure 1. Histopathologic
- Page 114: DISPATCHESFigure 2. Detection of fo
- Page 117 and 118: Influenza Virus Strains in the Amer
- Page 119 and 120: Novel Arenavirus Isolates from Nama
- Page 121 and 122: Novel Arenaviruses, Southern Africa
- Page 123 and 124: Readability of Ebola Informationon
- Page 125 and 126:
Readability of Ebola Information on
- Page 127 and 128:
Patients under investigation for ME
- Page 129 and 130:
Patients under investigation for ME
- Page 131 and 132:
Wildlife Reservoir for Hepatitis E
- Page 133 and 134:
Asymptomatic Malaria and Other Infe
- Page 135 and 136:
Asymptomatic Malaria in Children fr
- Page 137 and 138:
Bufavirus in Wild Shrews and Nonhum
- Page 139 and 140:
Bufavirus in Wild Shrews and Nonhum
- Page 141 and 142:
Range Expansion for Rat Lungworm in
- Page 143 and 144:
Slow Clearance of Plasmodium falcip
- Page 145 and 146:
Slow Clearance of Plasmodium falcip
- Page 147 and 148:
Gastroenteritis Caused by Norovirus
- Page 149 and 150:
Ebola Virus Stability on Surfaces a
- Page 151 and 152:
Ebola Virus Stability on Surfaces a
- Page 153 and 154:
Outbreak of Ciprofloxacin-Resistant
- Page 155 and 156:
Outbreak of S. sonnei, South KoreaT
- Page 157 and 158:
Rapidly Expanding Range of Highly P
- Page 159 and 160:
Cluster of Ebola Virus Disease, Bon
- Page 161 and 162:
Cluster of Ebola Virus Disease, Lib
- Page 163 and 164:
ANOTHER DIMENSIONThe Past Is Never
- Page 165 and 166:
Measles Epidemic, Boston, Massachus
- Page 167 and 168:
LETTERSInfluenza A(H5N6)Virus Reass
- Page 169 and 170:
LETTERSsystem (8 kb-span paired-end
- Page 171 and 172:
LETTERS3. Van Hong N, Amambua-Ngwa
- Page 173 and 174:
LETTERSTable. Prevalence of Bartone
- Page 175 and 176:
LETTERSavian influenza A(H5N1) viru
- Page 177 and 178:
LETTERSprovinces and a total of 200
- Page 179 and 180:
LETTERS7. Manian FA. Bloodstream in
- Page 181 and 182:
LETTERSforward projections. N Engl
- Page 183 and 184:
LETTERS3. Guindon S, Gascuel OA. Si
- Page 185 and 186:
BOOKS AND MEDIAin the port cities o
- Page 187 and 188:
ABOUT THE COVERNorth was not intere
- Page 189 and 190:
Earning CME CreditTo obtain credit,
- Page 191:
Emerging Infectious Diseases is a p